Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: Effects of toxicant exposures during deployment  by White, Roberta F. et al.
www.sciencedirect.com
c o r t e x 7 4 ( 2 0 1 6 ) 4 4 9e4 7 5Available online atScienceDirect
Journal homepage: www.elsevier.com/locate/cortexSpecial issue: ReviewRecent research on Gulf War illness and other
health problems in veterans of the 1991 Gulf War:
Effects of toxicant exposures during deploymentRoberta F. White a,*, Lea Steele b, James P. O'Callaghan c,
Kimberly Sullivan d, James H. Binns e, Beatrice A. Golomb f,
Floyd E. Bloom g, James A. Bunker h, Fiona Crawford i, Joel C. Graves j,
Anthony Hardie k, Nancy Klimas l, Marguerite Knox m, William J. Meggs n,
Jack Melling o, Martin A. Philbert p and Rachel Grashow q
a Department of Environmental Health, Boston University School of Public Health, Boston, MA, United States
b Baylor University Institute of Biomedical Studies, Waco, TX, United States
c Molecular Neurotoxicology, Toxicology & Molecular Biology Branch (MS-3014), Health Effects Laboratory Division,
Centers for Disease Control and Prevention e NIOSH, Morgantown, WV, United States
d Boston University School of Public Health, Department of Environmental Health, Boston, MA, United States
e Research Advisory Committee on Gulf War Veterans' Illnesses, Phoenix, AZ, United States
f University of California, San Diego, La Jolla, CA, United States
g Molecular & Integrative Neuroscience Department, The Scripps Research Institute, La Jolla, CA, United States
h National Gulf War Resource Center, Topeka, KS, United States
i Director, TBI Research Program, Roskamp Institute, Sarasota, FL, United States
j Captain, U.S. Army, Retired, Crestview, FL, United States
k Veterans for Common Sense, Bradenton, FL, United States
l Institute for Neuro-Immune Medicine, Nova Southeastern University, Miami, FL, United States
m McEntire Joint National Guard Base, Eastover, SC, United States
n Department of Emergency Medicine, 3ED311, The Brody School of Medicine, East Carolina University School of
Medicine, Greenville, NC, United States
o U.S. Government Accountability Office, Salisbury, Wiltshire, UK
p School of Public Health, Ann Arbor, MI, United States
q Northeastern University, Department of Civil and Environmental Engineering, Boston, MA, United States* Corresponding author. Department of Environmental Health, Boston University School of Public Health, 715 Albany St., T4W, Boston,
MA 02118, United States.
E-mail addresses: rwhite@bu.edu (R.F. White), Lea_Steele@baylor.edu (L. Steele), jdo5@cdc.gov (J.P. O'Callaghan), tty@bu.edu
(K. Sullivan), Binns.Jim@gmail.com (J.H. Binns), bgolomb@popmail.ucsd.edu (B.A. Golomb), fbloom@bloomsciassocs.net, fbloom@
scripps.edu (F.E. Bloom), desert-storm1991@outlook.com (J.A. Bunker), fcrawford@RFDN.ORG (F. Crawford), joelcgraves@gmail.
com (J.C. Graves), anthony.d.hardie@gmail.com (A. Hardie), nklimas@nova.edu (N. Klimas), marguerite.l.knox.mil@mail.mil (M.
Knox), meggsw@ecu.edu (W.J. Meggs), jmelling@ptd.net (J. Melling), Philbert@umich.edu (M.A. Philbert), r.grashow@neu.edu (R.
Grashow).
http://dx.doi.org/10.1016/j.cortex.2015.08.022
0010-9452/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
c o r t e x 7 4 ( 2 0 1 6 ) 4 4 9e4 7 5450a r t i c l e i n f o
Article history:
Received 20 March 2015
Reviewed 18 June 2015
Revised 19 August 2015
Accepted 28 August 2015
Published online 25 September 2015
Keywords:
Gulf War illness
Pesticide
Organophosphates
Sarin
Cyclosarin
Veterans' healtha b s t r a c t
Veterans of Operation Desert Storm/Desert Shield  the 1991 Gulf War (GW)  are a unique
population who returned from theater with multiple health complaints and disorders.
Studies in the U.S. and elsewhere have consistently concluded that approximately 25e32%
of this population suffers from a disorder characterized by symptoms that vary somewhat
among individuals and include fatigue, headaches, cognitive dysfunction, musculoskeletal
pain, and respiratory, gastrointestinal and dermatologic complaints. Gulf War illness (GWI)
is the term used to describe this disorder. In addition, brain cancer occurs at increased
rates in subgroups of GW veterans, as do neuropsychological and brain imaging
abnormalities.
Chemical exposures have become the focus of etiologic GWI research because nervous
system symptoms are prominent and many neurotoxicants were present in theater,
including organophosphates (OPs), carbamates, and other pesticides; sarin/cyclosarin
nerve agents, and pyridostigmine bromide (PB) medications used as prophylaxis against
chemical warfare attacks. Psychiatric etiologies have been ruled out.
This paper reviews the recent literature on the health of 1991 GW veterans, focusing
particularly on the central nervous system and on effects of toxicant exposures. In addi-
tion, it emphasizes research published since 2008, following on an exhaustive review that
was published in that year that summarizes the prior literature (RACGWI, 2008).
We conclude that exposure to pesticides and/or to PB are causally associated with GWI
and the neurological dysfunction in GW veterans. Exposure to sarin and cyclosarin and to
oil well fire emissions are also associated with neurologically based health effects, though
their contribution to development of the disorder known as GWI is less clear. Gene-
environment interactions are likely to have contributed to development of GWI in
deployed veterans. The health consequences of chemical exposures in the GW and other
conflicts have been called “toxic wounds” by veterans. This type of injury requires further
study and concentrated treatment research efforts that may also benefit other occupa-
tional groups with similar exposure-related illnesses.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The 1991 Gulf War (GW) was fought by a multinational coali-
tion that formed to oppose Iraq's invasion of Kuwait in 1990.
The coalition included nearly 700,000 U.S. troops as well as
military personnel from the United Kingdom, Canada,
Australia, and France, with over 30 partnering countries. It
began with a build-up of troops in the region (Operation
Desert Shield) prior to the actual conflict (Operation Desert
Storm), which included a six-week air campaign and four days
of ground fighting before a ceasefire was declared on February
28, 1991. This was followed by the return of themajority of the
troops by the spring of 1991. There were few casualties on the
winning side. The GW was remarkable for the numbers of
chemical exposures experienced by troops, including the low-
level chemical warfare agents released by the destruction of
Iraqi facilities, extensive spraying and use of pesticides,
medications given prophylactically to protect troops against
hazardous exposures, and hundreds of oil well fires set by the
Iraqi troops as they withdrew from Kuwait.
Within a year of return from the GW, it became apparent
that troops were suffering from a variety of symptoms that
were difficult to explain by health care providers, who did not
recognize a typical medical illness in the veterans. Initiallydubbed “GW syndrome” by the press, this disorder appeared
to affect many, but not all, GW veterans. Fatigue, widespread
pain, cognitive and memory problems, skin rashes, gastroin-
testinal and respiratory difficulties were commonly reported,
but not every veteran afflicted by GW illness (GWI) presented
with identical symptoms. Intensive research was initiated to
characterize the disorder, understand its prevalence, investi-
gate likely causes, and explore possible mechanisms of dis-
ease. Although the troops and some health care providers
immediately suspected that chemical exposures were the
cause of the condition, others ascribed GWI to post-traumatic
stress disorder (PTSD) or other psychiatric conditions, or to the
usual consequence of all wars. Effective treatments for GWI
have been elusive but recently a treatment research effort has
begun to flourish.
This paper explores the characteristics of GWI, its defini-
tion and prevalence (Epidemiology of GWI), the conditions in
theater that may have caused GWI and specific indictors of
nervous system dysfunction (Persistent Health Effects in GW
Veterans in Relation to Deployment Experiences and Expo-
sures), physiological mechanisms underlying GWI (Neuropa-
thology of GWI) and experimental models of GWI and its
causation (Animal Models of GWI Etiology and Pathology). It
also summarizes current evidence related to a variety of
neurological outcomes in addition to GWI that have been
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ical exposures encountered by veterans during the GW. The
paper is based on a recent summary of GWI research, Gulf War
illness and the health of Gulf War veterans: Research update and
recommendations, 2009e2013 (RACGWI, 2014), which our group
authored. The paper and its tables focus on the literature
appearing since 2008, with occasional briefer summaries or
tables on research published prior to 2008.2. The epidemiology of GWI
2.1. Case definitions and prevalence
Research on GWI has relied on a number of differing defini-
tions of the disorder, including chronic multisymptom illness
(CMI, Fukuda et al., 1998), the Kansas GWI definition (Steele,
2000), the Haley syndrome criteria (Haley, Kurt, & Hom,
1997) and adaptations of these approaches. CMI has been
used the most commonly in epidemiologic research to date.
GW veterans who meet criteria for CMI must report one or
more symptoms that have been ongoing for at least six
months in two of three categories, which include musculo-
skeletal pain (symptom list: joint pain, joint stiffness, muscle
pain); mood-cognition (feeling depressed, feeling moody,
feeling anxious, trouble sleeping, difficulty remembering or
concentrating, trouble with word finding), and fatigue. CMI
can be categorized as “severe” if the veteran rates each
defining symptom as severe or “mild-moderate” for milder
complaints. This case definition was recommended for clin-
ical use by a recent IOM panel (IOM, 2014). The Kansas defi-
nition of GWI requires that cases have moderately severe or
multiple chronic symptoms in at least three of six categories:
fatigue/sleep problems, pain, neurological/cognitive/mood
symptoms, respiratory complaints, gastrointestinal problems
or skin symptoms (Steele, 2000). Veterans who have severe
psychiatric disorders or other medical conditions that might
predict similar symptoms are excluded. The 2014 IOM report
on GWI case definitions recommended that this definition be
used for research purposes (IOM, 2014). The Haley syndromes
were originally developed using factor analytic evaluation of
symptom data from a Seabees unit and include three symp-
tom complexes. Syndrome 1 (Impaired cognition) is charac-
terized by problems with attention, memory, and sleep along
with depression. Syndrome 2 (Confusion/ataxia) involves
problems with thinking and balance. Syndrome 3 (Neuro-
pathic pain), is defined by joint and muscle pain.
Each of these definitions has particular strengths and
weaknesses. The mild form of CMI is broad and overly inclu-
sive, resulting in high prevalence rates even in control pop-
ulations, though the severe form appears to be more specific
to GWI (Nisenbaum, Barrett, Reyes, & Reeves, 2000). The
Kansas criteria predict GWI at rates that appear to be consis-
tent with those seen across multiple GW populations but can
potentially exclude veterans with some concurrent medical
disorders who may also have GWI. The Haley syndromes are
quite narrow and underestimate the occurrence of the disor-
der but may allow highly specific characterization of veterans
whomeet criteria for a syndrome.When used in research, use
of one of these definitions at least provides a basis forunderstanding the health characteristics of GWI cases being
described. Many studies have not included any clear defini-
tion of how GWI was diagnosed among cases, a serious
problem for the literature on this disorder. The ultimate goal
of a consensus case definition for GWI has been advocated,
which would lead to greater clarity in GWI research (RACGWI,
2014).
Because the individual symptoms seen in GWI can occur
commonly in the general population, it is important to iden-
tify the excess rates of such symptoms in the GW veteran
population, that is, the proportion of 1991 GW veterans who
experienced multiple chronic symptoms over and above the
“background” rate of these symptoms seen in contemporary
veterans who did not deploy to the GW theater. Using the
definitions of GWI described above, the 2008 RAC report
compared the rates of the symptoms of the disorder in
deployed GW veterans with those seen in control groups to
provide a consistent methodology for estimating the preva-
lence of symptomatic illness attributable to GW service across
studies.
Table 1 provides prevalence data from nine investigations
that used this approach and three studies that provide esti-
mates only for GW veterans. Seven of ten estimates indicated
excess rates of symptomatology to be in the 25e32% range
across multiple populations when using the more general
case definitions for GWI (CMI, Kansas), while the more
narrowly focused factor analytic case definitions such as the
Haley criteria produced lower estimates of the disorder. Lon-
gitudinal studies have consistently indicated that GWI rates
and symptom frequencies reported by veterans have
remained fairly constant, with no overall improvement over
time (Hotopf et al., 2003; Ozakinci, Hallman, & Kipen, 2006;
Proctor et al., 1998; Wolfe, Proctor, Erickson, & Hu, 2002).
2.2. Neurological conditions
Rates of neurological conditions that have been evaluated
among deployed GW veterans compared to nondeployed
controls include amyotrophic lateral sclerosis (ALS), brain
cancer, seizures, neuritis and neuralgia, migraine headaches,
multiple sclerosis (MS) and Parkinson's disease (PD). The
literature appearing on these disorders since 2008 is summa-
rized in Table 2.
The neurological disorder that was first identified as
occurring at increased rates in GW veterans was ALS. Prior to
2008, several studies had reported an excess rate of ALS
among deployed GW veterans relative to nondeployed con-
trols (Coffman, Horner, Grambow, & Lindquist, 2005; Horner
et al., 2008). Some findings suggested that age of onset might
be earlier in this population (Haley, 2003). However, Horner
et al. (2008) reported that the increased rate of ALS in GW
versus nondeployed veterans was maintained only for the
first 10 years after the war, peaking in 1996, suggesting a time-
limited ALS “outbreak” in GW veterans (Horner et al., 2008).
ALS risk was also reportedly related to specific locations of
affected troops in theater (Miranda, Galeano, Tassone, Allen,
& Horner, 2008). Two studies appearing since 2008 have
examined the occurrence of ALS. One paper compared the
characteristics of ALS in GW-deployed and era nondeployed
veterans, concluding that age, site of onset and symptom
Table 1 e Population-based prevalence estimates: chronic symptomatic illness in 1991 Gulf War veterans and nondeployed era veterans.
Study Gulf War veterans
assessed
Year(s) of
assessment
Case definition used Prevalence in
Gulf War veterans
Prevalence in
nondeployed veterans
Excess illness in
Gulf War veterans
Fukuda et al., 1998 1,155 Air Force veterans 1995 CMI 45% 15% 30%
Unwin et al., 1999 4,428 U.K. male veterans 1998 CMI (modified) 62% 36% 26%
Steele, 2000 1,548 Kansas veterans 1998 Kansas GWI
CMI
34%
47%
8%
20%
26%
27%
Proctor, Harley, Wolfe, Heeren,
&White, 2001
180 New England
Army veterans
1994e1996 CMI (modified) 65% 33% 32%
Unwin et al., 2002 226 U.K. female veterans 1998 CMI (modified) 64% 35% 29%
Blanchard et al., 2006 1,035 U.S. veterans 1999e2001 CMI (modified)a 29% 16% 13%
King, King, Bolton, Knight, &
Vogt, 2008
357 U.S. veterans 2001 CMI 54% not evaluated e
Kang, Li, Mahan, Eisen, & Engel,
2009
6,111 U.S. veterans 2005 VA-defined
multisymptom illnessb
37% 12% 25%
Kelsall et al., 2009 1,381 Australian veterans 2000e2002 Australian factor definition 26% 16% 10%
Iannacchione et al., 2011 5,699 U.S. veterans 2007e2009 Haley factor definition
(3 syndromes combined)
14% 4% 10%
Smith et al., 2012 317 U.S. veterans 2001 CMI 50%c
34%c
not evaluated e
Steele, Sastre, Gerkovich, &
Cook, 2012
646 Kansas City
area veterans
2000 CMI 45% not evaluated e
Abbreviations: CMI ¼ chronic multisymptom illness, as defined in Fukuda et al. (1998); Kansas GWI ¼ Kansas Gulf War illness as defined in Steele (2000); VA ¼ Department of Veterans Affairs.
a CMI modification replaced fatigue criterion with fatigue lasting >24 h after exertion.
b Unexplained multisymptom illness defined as multiple types of symptoms occurring together, not explained by medical/psychiatric diagnoses.
c Unweighted sample prevalence ¼ 50% (prevalence estimate weighted to reflect general population ¼ 34%).
(Table adapted from RACGWI, 2014).
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Table 2 e Studies reporting on diagnosable neurological conditions in Gulf War veterans.
Study Groups studied Outcome(s) Key findings
Barth et al., 2009 621,902 GWV, 746,248 NDV Mortality due to brain cancer,
MS, PD, and ALS
GWV potentially exposed to nerve
agents over multiple days and GWV
with greatest exposure to oil well fires
had significantly higher rates of brain
cancer mortality. Overall, mortality
due to brain cancer, PD, MS, ALS similar
in GWV and NDV.
Kang et al., 2009 6,111 GWV, 3,859 NDV Diagnosed medical conditions
reported by veterans
Compared to NDV, GWV reported
significantly higher rates of repeated
seizures, neuralgia/neuritis, and stroke.
Kasarskis et al., 2009 43 deployed GWV with ALS,
66 nondeployed GWV with ALS
ALS age of onset, site of onset,
atypical symptom features,
ventilator-free survival time
No differences between ALS symptoms,
age and site of onset similar for deployed
GWV versus nondeployed. Ventilator-free
survival time post-diagnosis was
significantly shorter in deployed GWV.
Wallin et al., 2012 2,691 veterans who served
in the military between
1990 and 2007, and had applied
for VA benefits for MS
MS incidence by age, sex,
race and branch of service
No determination of MS rates specifically
in relation to 1991 Gulf War era or
deployment. MS incidence was
significantly higher in females than
males, blacks versus other races,
and in Air Force and Army veterans
versus other branches.
Rayhan, Raksit, et al.,
2013; Rayhan,
Ravindran, et al., 2013;
Rayhan, Stevens,
et al., 2013
50 symptomatic GWV, 39 CFS
patients, 45 sedentary controls
Structured headache
evaluation
Statistically similar proportions of GWV
(64%) and CFS (82%) patients affected by
migraines; both significantly greater than
controls (13%).
Wallin et al., 2014 387 GWV and 1,454 NDV who
filed for disability benefits
due to MS and ODD
MS incidence in GW-era
veterans by age, sex, race and
branch of service
MS incidence estimates (using entire
active duty population of GWV and
NDV as denominators), indicated no
significant MS differences between
GWV and NDV.
Abbreviations: GWV ¼ Gulf War veterans; NDV¼nondeployed veterans; ALS ¼ amyotrophic lateral sclerosis; PD¼ Parkinson's disease,
MS ¼ multiple sclerosis; CFS ¼ chronic fatigue syndrome, ODD¼ other demyelinating disease.
(Table adapted from RACGWVI, 2014).
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ventilator-free survival time was shorter in the GW-deployed
ALS patients (Kasarskis et al., 2009). A second study concluded
that there was no excess mortality from ALS in deployed GW
veterans compared to nondeployed era controls (Barth, Kang,
Bullman, & Wallin, 2009).
Two studies have found excess rates of death due to brain
cancers among GW veterans who were identified by Depart-
ment of Defense (DoD) exposure models as having been
possibly exposed to nerve gas agents during/following the
demolition of the weapons depot in Khamisiyah, Iraq, in
March of 1991 (Barth et al., 2009; Bullman, Mahan, Kang, &
Page, 2005). Veterans exposed to the highest levels of con-
taminants from oil well fires were also reported to have
increased rates of brain cancer deaths (Barth et al., 2009).
The VA's 2005 national longitudinal survey of nearly 9,000
GW era veterans published in 2009 (Kang et al., 2009) found
that deployed veterans reported being diagnosed with
repeated seizures, neuralgia or neuritis, and stroke at greater
rates than nondeployed era controls. Most of these conditions
had also been reported at excess rates by GW veterans in VA's
1996 national survey. Although these conditions were self-
reported, medical record reviews for both the 1996 and 2005
VA national surveys indicated a high percent agreement(93e96%) between medical records and veteran-identified
reasons for clinic visits and hospital stays (Kang et al., 2009;
Kang, Mahan, Lee, Magee, & Murphy, 2000).
Increased rates of migraine headaches have been reported
for some time among GW deployed veterans relative to con-
trols (Gray, Reed, Kaiser, Smith,&Gastanaga, 2002; Kang et al.,
2000; Steele, 2000; Unwin et al., 1999). In GWveteranswhomet
clinical criteria for chronic fatigue syndrome (CFS), 64% were
diagnosed with migraine headaches, which is a rate similar to
nonveteran subjects with CFS and significantly higher than
that seen in sedentary controls (Rayhan, Ravindran, &
Baraniuk, 2013).
There are no reliable data on incidence or prevalence of
MS or PD among veterans of the 1991 GWspecifically. As noted
in Table 2, a paper published in 2009 (Barth et al., 2009)
concluded that GW veterans, overall, did not have higher
mortality rates due to these disorders, compared to non-
deployed era veterans. A study of MS in veterans who served
in the military between 1990 and 2007 and had applied for
disability compensation identified increased MS rates in
women, African Americans, and Army veterans compared to
other groups but did not focus specifically on deployed vet-
erans of the 1991 GW (Wallin et al., 2012). A later report indi-
cated that rates of MSwere not significantly different between
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cohort (Wallin et al., 2014). Neither mortality data nor the
number of veterans seeking disability benefits for MS provides
a valid indication of whether GW veterans have been affected
by excess rates of MS or most other neurological disorders
since the war. Determining the impact of MS and other
neurological disorders on GW veterans requires clear preva-
lence figures derived fromwell-designed research that utilizes
population-based samples of GW veterans and appropriate
comparison groups. It is also important to determine if rates of
these disorders differ in GW veteran subgroups in connection
with exposures or other deployment characteristics.
Reports summarizing the research on health problems in
GW veterans have repeatedly emphasized that it is essential
that studies intended to evaluate rates of illness and diag-
nosable diseases in GW veterans determine those rates in
appropriate veteran subgroups, defined by particular expo-
sures, locations in theater, or other relevant factors (RACGWI,
2008, 2014). It is now well understood that deployment expo-
sures and experiences encountered by GW veterans were not
uniform across theater. General analyses that combine all GW
veterans into a single group will underestimate or completely
obscure important findings associated with exposures that
affected only a subgroup of veterans. This has been well
illustrated, for example, by studies identifying excess rates of
brain cancer mortality (Barth et al., 2009), brain structure and
cognitive alterations (Chao, Abadjian, Hlavin, Meyerhoff, &
Weiner, 2011; Heaton et al., 2007; Proctor, Heaton, Heeren, &
White, 2006) and respiratory disease (Cowan, Lange, Heller,
Kirkpatrick, & DeBakey, 2002) among veteran subgroups who
had the greatest exposure to nerve agents or oil fire smoke
during the GW.
2.3. Psychiatric and psychological disorders
Deployment related stress, PTSD and other psychiatric con-
ditions were extensively studied in GW veterans immediately
after their complaints of increased ill health became known.
Population-based studies indicated that rates of diagnosed
PTSD in GW veterans were about 3e6%, compared to a rate of
25e32% for GWI (RACGWI, 2008). When combat stressors, self-
reported stress reactions and exposures to other stressful
events in theater were quantified, these variables did not
explain or predict diagnosis of GWI (RACGWI, 2008, p. 78). The
2010 IOM report on GWI concluded: “The excess of unex-
plainedmedical symptoms reported by deployed GWveterans
cannot be reliably ascribed to any knownpsychiatric disorder”
(IOM, 2010, p. 109).
Research studies investigating PTSD since 2008 are sum-
marized in Table 3. These studies have concluded that PTSD
symptom severity was associated with poorer physical health
after deployment (Hassija, Jakupcak, Maguen, & Shipherd,
2012), that exposure to war casualties was associated with
greater mental health decline (Gade &Wenger, 2011) and that
combat exposure was related to PTSD, depressive symptoms
and alcohol abuse (Hassija et al., 2012). Problem drinking in
the GW population was found to be associated with PTSD,
major depression and multisymptom illness (Coughlin, Kang,
& Mahan, 2011). National Guard/Reservists and troops on
active duty scored higher on PTSD rating scales and reportedincreased perceived threats and difficult living and working
environments while deployed than comparison service men
and women (Vogt, Samper, King, King, & Martin, 2008).
The literature on neuroimaging and PTSD in deployed GW
veterans mirrors PTSD findings in other veteran populations,
including neuropathological and hormonal changes. GW vet-
erans with PTSD were found in one study to have smaller
hippocampal volumes on brain imaging than controls without
PTSD (Apfel et al., 2011). Diminished hippocampal volume,
metabolic activity changes and enhanced hormonal response
to dexamethasone were reported in a second study of GW
veterans diagnosed with PTSD (Yehuda et al., 2010). GW vet-
erans diagnosed with combat-related PTSD showed smaller
volume, area and thickness values in the hippocampal gyrus,
superior temporal cortex, lateral orbital frontal cortex and
pars orbitalis brain regions when compared to veterans
without PTSD in a third investigation (Woodward, Schaer,
Kaloupek, Cediel, & Eliez, 2009). Although these studies sug-
gest that PTSD should be assessed and accounted for when
evaluating neuroimaging outcomes in GW veterans, none of
the reported studies controlled for potential nerve agents or
other relevant environmental exposures that should also be
assessed when evaluating magnetic resonance imaging (MRI)
outcomes in this population.
Overall, research on PTSD and other psychiatric disorders
among GW veterans shows lower rates of these conditions
than are found in veterans of other wars and far lower than
the prevalence of GWI. However, related physiology and pre-
dictors of PTSD occurrence and severity are similar.3. Research on persistent health effects in
GW veterans in relation to deployment
experiences and exposures
Exposures in the GW theater that have been suspected of
contributing to long-term health effects after the war include
pesticides, depleted uranium munitions, airborne contami-
nants from the Kuwaiti oil well fires, chemical nerve agents,
the anthrax vaccine and multiple vaccinations, widespread
use of pyridostigmine bromide (PB) as a prophylactic measure
against possible nerve agent exposure, chemical resistant
coating (CARC) paint, and other hazards such as psycholog-
ically stressful conditions and heat. Military personnel
commonly experienced multiple exposures in different com-
binations, for which possible interactive or synergistic effects
have not been determined in human populations. One of the
central challenges in evaluating risk factors for GW-related
health outcomes involves a paucity of data on the types and
doses of exposures experienced by veterans in theater. Initial
research efforts on exposureeoutcome relationships in this
population were forced to rely on self-report, which can be
subject to bias. To address this concern, the U.S. DoD spon-
sored a number of intensive efforts to provide simulations,
modeled estimates and detailed investigations in an effort to
better characterize wartime exposures in different locations
and military units. These include estimates of nerve agent
exposures following demolitions at the massive munitions
depot at Khamisiyah, Iraq, in March of 1991; modeled esti-
mates of levels of airborne contaminants from the hundreds
Table 3 e Studies reporting on psychiatric and psychological disorders in Gulf War veterans.
Study Groups studied Outcome(s) Key findings
Vogt et al., 2008 81 active duty GWV and
230 NG/R GWV
DRRI, PTSS High PT and DLWE scores on the DRRI
and PTSS were significantly stronger
for active duty women and NG/R men.
Woodward et al., 2009 50 PTSDþ (13 GWV and 37 VV)
and 47 PTSD- (23 GWV and 24 VV)
Cortical volume measured
using MRI
Subjects with combat-related PTSD
showed significantly smaller cerebral
cortical volume, thickness and area
compared to PTSD- controls.
Yehuda et al., 2010 12 PTSD þ GWV and 9 PTSD-GWV Plasma ACTH changes,
declarative memory,
MRI, PET, DST
PTSD þ group showed significantly
greater cortisol and ACTH suppression.
Hippocampal volume difference and
greater hippocampal metabolic activity
seen in PTSD þ GWV. No memory
differences were seen.
Apfel et al., 2011 82 GWV with lifetime PTSD,
44 GWV with current PTSD,
38 GWV with MDD, 80 PTSD-GWV
Hippocampal volume
measured using MRI
GWV with chronic PTSD had smaller
hippocampal volume than GWV without
current PTSD. Current PTSD symptoms
were associated with significantly
reduced hippocampal volume.
Coughlin et al., 2011 6,111 deployed GWV, 3,859
nondeployed veterans
Alcohol use, PTSD, MDD Problem drinking was significantly
and positively associated with PTSD
and MDD
Gade &Wenger, 2011 1035 GWV, 3452 VV MCS Exposure to war casualties but not
combat overall was associated with
mental health decline. Negative
effects of combat were larger
for GWV compared to VV.
Hassija et al., 2012 87 GWV and 43 OIF/OEF veterans PSS, DSS, alcohol misuse Combat exposure was significantly
associated with PSS, DSS and
alcohol misuse.
Wachen et al., 2013 317 GWV PSS, PCL, PHS Significant associations between
post-deployment physical health
and PSS in all symptom categories.
PSS score was more strongly related
to physical health for subjects with
lower warzone exposures, but also
significant for high warzone exposures.
Abbreviations: GWV¼ Gulf War veterans; MDD ¼major depressive disorder; PTSD¼ post-traumatic stress disorder; PTSDþ¼meets the criteria
for current PTSD resulting from one ormoremilitary trauma; PTSD¼ did not meet criteria for PTSD, either current or lifetime; MRI¼magnetic
resonance imaging; MSI ¼ multisymptom illness; MCS ¼ Mental Component Summary; VV¼Vietnam veterans; OEF¼Operation Enduring
Freedom; OIF¼Operation Iraqi Freedom, PSS¼ post-traumatic stress disorder symptom severity; DSS ¼ depressive symptom severity;
PTSS¼ post-traumatic stress symptomatology; DRRI¼Deployment Risk and Resilience Inventory; PT¼ perceived threat; DLWE¼ difficult living
and working environment; NG/R ¼ National Guard/Reserve; PCL¼ Post-traumatic Stress Disorder Checklist; PHS ¼ physical health symptoms;
ACTH ¼ adrenocorticotropic hormone; PET ¼ positron emission tomography; DST ¼ dexamethasone suppression test.
(Table adapted from RACGWVI, 2014).
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metal exposures associated with depleted uranium muni-
tions, and in-depth investigations that provided detailed in-
formation on the use of pesticides and PB in theater. The
hazards that have been studied most extensively with regard
to health outcomes in this population include psychological
stressors, pesticides, PB, sarin/cyclosarin, vaccines, depleted
uranium and oil well fires.
Early exposure-related studies in the deployed GW veteran
populationwere often problematic, due to analytic limitations
that led to errors in interpretation of study findings. Such
problems arose when studies that assessed myriad potential
risk factors for GWI failed to control for confounding due to
effects of concurrent exposures. Such studies typically re-
ported that all, or most, GW experiences and exposures
evaluated were significantly associated with GWI (RACGWI,2008). In contrast, studies that evaluated individual GWI risk
factors, while controlling for effects of other exposures,
invariably identified a limited number of significant risk fac-
tors for GWI. Across all studies and populations, when con-
founding effects of concurrent exposures are considered,
pesticide and PB use during the GW have been consistently
identified as significant risk factors for GWI.
3.1. Pesticide exposures
As detailed elsewhere (DOD, 2001), GW personnel were often
exposed to high levels of a variety of pesticides and insect
repellants in theater. After adjusting for effects of concurrent
exposures, significant associations between self-reported
pesticide exposure and GWI, variously defined, have been
identified in six of the seven different GW veteran populations
c o r t e x 7 4 ( 2 0 1 6 ) 4 4 9e4 7 5456in which they have been evaluated (RACGWI, 2008; Steele
et al., 2012). Pesticide exposures were associated with GWI
as defined by the Haley syndrome criteria in veterans from a
single Navy unit (Haley&Kurt, 1997), CMI in Air Force veterans
(Nisenbaum et al., 2000), study-specific criteria among Navy
Seabees (Gray et al., 2002), overall symptom severity among
United KingdomGWveterans (Cherry et al., 2001a, 2001b), and
gastrointestinal and/or neuropsychological symptoms in
DanishGWveterans (Ishoy, Suadicani, Guldager, Appleyard,&
Gyntelberg, 1999; Ishoy, Suadicani, Guldager, Appleyard, Hein,
et al., 1999; Suadicani, Ishoy, Guldager, Appleyard, &
Gyntelberg, 1999). In a more recent study, Steele et al. (2012)
also found an association between pesticide exposures and
GWI for veterans who had served in different locations in
theater. In addition, two studies have reported doseeresponse
effects in the association between pesticide exposures and
GWI (Cherry et al., 2001b; Haley & Kurt, 1997).3.2. PB
The 1991 GW is the only conflict in which PB was widely used
by military personnel as a prophylactic measure intended to
protect against effects of possible nerve gas attacks (Golomb,
1999). Self-reported PB use has also been consistently linked
to ill health in GW veteran populations (see Table 4). Use of PB
and/or experiencing side effects from PB were significantly
associated with Haley syndrome symptomatology (Haley,
Kurt, et al., 1997), with study-specific criteria for GWI among
Navy Seabees (Gray et al., 2002), CMI in U.S. Air Force
(Nisenbaum et al., 2000) and Army (Wolfe et al., 2002) veter-
ans, a study-specific diagnosis of GWI in Oregon veterans
(Spencer et al., 2001), and overall symptom severity in U.K. GW
veterans (Cherry et al., 2001b). In a more recent study, PB use
was associated with a significantly elevated risk for GWI
(OR ¼ 3.5) among GW veterans who were located in forward
areas in theater (Steele et al., 2012). Overall, self-reported PB
use has been identified as a significant risk factor for GWI in all
seven populations in which it has been evaluated, after
adjusting for the effects of other exposures. Three studies
have reported doseeresponse effects for GWI in relation to PB
use (Cherry et al., 2001b; Spencer et al., 2001; Wolfe et al.,
2002), and two have identified doseeresponse effects in rela-
tion to side effects from PB use (Cherry et al., 2001b; Haley &
Kurt, 1997).3.3. Chemical warfare agents
Several studies have linked sarin/cyclosarin exposure to
central nervous system outcomes. The 2008 RAC report
summarized studies from Boston investigators that examined
the relationship between brain outcomes and DoD models of
sarin/cyclosarin nerve gas agent exposures resulting from the
demolition of the Khamisiyah, Iraq, weapons depot in March
1991. Thismodeling provided a dose exposure estimate across
three days as well as identification of U.S. troops who were
likely in the area. Investigators found that reduced perfor-
mance on neurobehavioral tests (Proctor et al., 2006) and
smaller white matter volumes on brain imaging (Heaton et al.,
2007) were associated with nerve gas agent exposure in adose-dependent manner, with higher exposures predicting
poorer performance and less overall brain white matter.
The findings of associations between DoDmodels of sarin/
cyclosarin exposure and MRI and behavioral outcomes have
received support from recent investigations. In the first, gray
matter and hippocampal volumes were found to be smaller in
Khamisiyah-exposed veterans versus non-exposed veterans,
and reduced white matter volume measured on a 1.5 T MRI
was associated with poorer performance on neurobehavioral
tests of executive and visuospatial functions (Chao, Rothlind,
Cardenas, Meyerhoff, & Weiner, 2010). A second study from
Chao et al. using a 4.0 T MRI and a different study sample
found that total gray and total white matter volumes were
both significantly reduced in Khamisiyah-exposed veterans,
though findings were inconsistent regarding exposure-related
cognitive differences (Chao et al., 2011). An additional study
evaluating neurobehavioral outcomes found slower motor
function speeds among Khamisiyah-exposed veterans
compared to non-exposed (Toomey et al., 2009).
Two studies have reported significantly increased rates of
death due to brain cancer among veterans who were located
within the nerve agent plume area defined by DoD models of
the Khamisiyah demolitions. The earlier study, reporting on
mortality through 2000, identified a nearly two-fold increase
in brain cancer deaths in exposed veterans (Bullman et al.,
2005). The observed increase was further supported by a
2009 VA study that evaluated mortality rates through 2004,
which found a nearly three-fold increase in brain cancer
deaths among veterans with the highest level of exposure to
the Kuwaiti oil well fires and nerve agents associated with the
Khamisiyah plume (Barth et al., 2009).
In a large national study, Haley et al. (2013) explored the
relationship between chemical agent exposures and GWI.
This group reported an increased risk for GWI defined as CMI
or the Haley syndromes associated with hearing chemical
alarms in theater, a proxy for possible nerve agent exposure. A
significant doseeresponse effect in which veterans who re-
ported hearing more alarms had greater risk for GWI was re-
ported in this study. In contrast, this study reported no
association between GWI and modeled exposure to the Kha-
misiyah plume, which contained these agents. A study of
Kansas City-area GW veterans did not reveal associations
between hearing chemical alarms and risk for GWI (Steele
et al., 2012).
In summary, the literature appearing prior to 2008 and
since then clearly supports a link between adverse neurolog-
ical outcomes and sarin/cyclosarin in populations of GW
veterans with exposure to these agents. The link between
such exposures and GWI remains unclear, perhaps because
studies on the issue over time have assessed nerve gas agent
exposure in different ways (self-report, chemical alarms,
Khamisiyah models) and defined GWI differently.
Only limited evidence is available regarding exposures to
and health effects of other chemical warfare agents known to
have been present in theater. A study published in 2013
tracked meteorological patterns in the region and indicated
that U.S. troops may have been exposed to both nerve and
blister agents as fallout from the Coalition bombing of
chemical storage sites in 1991, during the early days of the air
campaign (Tuite & Haley, 2013). This possibility had
Table 4 e Association of pyridostigmine bromide and pesticide exposures with symptomatic illness in Gulf War veteran populations.
Study Gulf War veterans
studied
Symptomatic illness
evaluated
Association of exposure with symptomatic illness
(adjusted for effects of other exposures)
Additional information
PB Pesticides, repellants
Haley & Kurt, 1997 249 GWV Navy Seabees Haley syndromes þ1 þ PB side effects “dose response”
effect; DEET dose response effect
Ishoy, Suadicani,
Guldager, Appleyard,
& Gyntelberg, 1999
686 Danish GWV Gastrointestinal and/or
neuropsychological symptoms
na þ
Nisenbaum et al., 2000 1,002 Air Force GWV CMI þ þ
Cherry et al., 2001b 7,971 U.K. GWV Overall symptom severity þ2 þ PB dose response effect; Pesticide
dose response effect
Spencer et al., 2001 1,119 GWV from
Washington, Oregon
Gulf War unexplained
illness (study defined)
þ  PB dose response effect; DEET was
only pesticide evaluated in model
Gray et al., 2002 3,831 GWV Navy Seabees Gulf War illness
(study defined)
þ þ
Wolfe et al., 2002 945 Army GWV CMI þ na PB dose response effect
Steele et al., 2012 304 Kansas GWI þ þ PB association most pronounced
in forward deployed GWV
Abbreviations: PB ¼ pyridostigmine bromide; GWV ¼ Gulf War veterans; CMI ¼ chronic multisymptom illness, as defined in Fukuda et al. (1998); Kansas GWI ¼ Kansas Gulf War illness as defined in
Steele (2000); DEET ¼ NIN-diethyl-meta-toluamide.
þ¼ statistically significant association; ¼ association not statistically significant; na ¼ not assessed.
Notes: 1 ¼ association with PB side effects only, 2 ¼ association with PB use and PB side effects.
(Table adapted from RACGWVI, 2008).
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Table 5 e Studies assessing exposures associated with health outcomes in Gulf War veterans.
Study Groups studied Exposure(s) Method(s) Key findings
Neurological and neuropsychological
Toomey et al., 2009 1,061 deployed GWV;
1,128 nondeployed veterans
PB, pesticides, vaccines,
IG injections, oil well fire smoke
Neuropsychological
testing
Deployed GWV had significantly lower scores on tests of verbal memory,
verbal learning, motor speed, and attention than nondeployed.
Specific exposure in Khamisiyah was negatively correlated
with motor speed.
Chao et al., 2010 40 exposed GWV,
40 unexposed GWV
Sarin and cyclosarin MRI, neuropsychological
testing
Significantly reduced gray matter and hippocampal volumes in
sarin and cyclosarin exposed subjects. White matter volume was
associated with executive function and visuospatial abilities in
exposed veterans.
Chao et al., 2011 64 exposed GWV,
64 unexposed GWV
Sarin and cyclosarin MRI, neuropsychological
testing
Sarin/cyclosarin exposed GWV showed sign. reduced total gray
and white matter volumes compared to unexposed controls.
GWI/CMI diagnosis sign. predicted gray and white matter volumes
in sarin/cyclosarin exposed subjects. Exposed GWV performed sign.
worse on a continuous performance test of attention, but better on
psychomotor function (Trailmaking Test A and Grooved Pegboard).
Cancer mortality
Barth et al., 2009 621,902 GWV,
746,248 nondeployed veterans
Sarin/cyclosarin
Oil well fire contaminants
Brain cancer mortality,
brain cancer, ALS, MS, PD
Significant increase in brain cancer mortality among GWV in sarin
exposure area 2 days; sign. dose response effect for number of
days of exposure. Oil fire associated with sign. increase in brain
cancer mortality among exposed Army GWV, compared to
non-exposed. No interaction found between oil well fires and
sarin exposure.
Health status
Kelsall et al., 2009 698 Australian GWV Vaccines Total symptom number,
SF-12 physical component,
GHQ-12 case status
Number of self-reported vaccines weakly associated with total
number of symptoms and poorer health; relationship not seen
with recorded vaccination number.
Genotyping
Steele et al., 2015 144 GWI cases,
160 GWV controls
Exposures or exposure indicators
with possible cholinergic effects
(PB, pesticides, hearing
chemical alarms)
Association of BChE
genotype with GWI
geneeexposure interactions
No association of BChE genotype overall with GWI; significant
geneeexposure interaction for PB only; GWV with less active
BChE variants (KK, A, F heterozygotes) who used PB had
significantly greater GWI risk (OR ¼ 40.0) than GWV with more
active UU & UK genotypes (OR ¼ 2.7)
GWI and CMI
Phillips et al., 2009 175 male U.S. Navy
Seabees GWV
Vaccines (squalene antibodies) CMI Similar proportions of CMI (55%) and healthy (51%) GWV were
positive for squalene antibodies (p ¼ .71).
Steele et al., 2012 304 Kansas City
area GWV
PB, pesticides, vaccines, oil well
fire smoke, chemical alarms
GWI Pesticide use significantly associated with GWI for veterans who
were in Iraq or Kuwait and for veterans in support areas. Use of PB,
close proximity to exploded SCUD missile and exposure to oil well
fire smoke significantly associated with GWI for personnel in
forward areas only; GWI not associated with serving in combat,
hearing chemical alarms.
Haley et al., 2013 8,020 GWV Chemical alarms, DoD-modeled
Khamisiyah exposure area
GWI GWI was significantly associated in a doseeresponse manner with
hearing chemical alarms but not with exposure to Khamisiyah plume
Abbreviations: GWV¼GulfWar veterans; GWI¼GulfWar illness; PB¼ pyridostigmine bromide pills; MRI¼magnetic resonance imaging; IG¼ immunoglobulin; ACTH¼ adrenocorticotropic hormone;
CRF ¼ corticotrophin-releasing factor; CMI ¼ chronic multisymptom illness; SF-12 ¼ Short-Form Health Survey 12 items; PCS¼ Physical Component Summary Score; GHQ-12 ¼ General Health
Questionnaire; DoD ¼ Department of Defense, ALS ¼ amyotrophic lateral sclerosis; PD¼ Parkinson's disease; MS ¼ multiple sclerosis; SCUD ¼ Subsonic Cruise Unarmed Decoy;
BChE ¼ butyrylcholinesterase.
(Table adapted from RACGWVI, 2014).
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c o r t e x 7 4 ( 2 0 1 6 ) 4 4 9e4 7 5 459previously been raised by multiple sources, including Czech
and other Coalition partners who reported chemical de-
tections in northern Saudi Arabia in January of 1991, with
related evidence summarized in a 2004 report from the U.S.
Government Accountability Office (U.S. Department of
Defense Office of the Special Assistant for Gulf War
Illnesses, 1998; U.S. General Accounting Office, 2004). Chemi-
cal detection monitors used during the war had limited ca-
pabilities for detecting mustard gas, but government reports
have verified the presence of mustard gas at chemical
manufacturing and storage sites in Iraq (U.S. Central
Intelligence Agency, Persian Gulf War Illnesses Task Force,
2002) and in munitions stored at the Khamisiyah weapons
depot (U.S. Department of Defense Office of the Special
Assistant for Gulf War Illnesses, 2002). A 2012 study
described a mechanism by which mustard gas may have
interacted with other exposures in theater in contributing to
long-term health effects in GW veterans (Brimfield, 2012).
However, there are no reports in the literature providing sys-
tematic evaluation of the effects of mustard gas on the health
of GW veterans.
3.4. Other exposures and chemical mixtures
Previous evidence that links GWI to individual vaccines and/or
the total number of vaccines received by GW veterans is quite
limited (Research Advisory Committee, 2008). Prior to 2008,
one study identified a significant association between GWI
and the number of vaccines received after controlling for the
effects of other exposures in theater (Cherry et al., 2001b). A
2009 Australian study reported a weak association between
health symptoms affecting GW veterans and the number of
vaccines received, but no associations with vaccines reported
in military records (Kelsall et al., 2009). Similarly, no associa-
tions between GWI and vaccines received in theater were re-
ported in a 2012 study of Kansas City-area veterans (Steele
et al., 2012). Some investigators have suggested that certain
vaccines used during the GW contained squalene, which
potentially gave rise to antibodies that might be associated
with GWI (Asa, Cao, & Garry, 2000). However, a 2009 study
found no association between diagnosis of CMI and the
presence of squalene antibodies in Navy Seabees who served
in the GW (Phillips et al., 2009).
Earlier studies provided mixed conclusions on the long-
term health effects of exposures resulting from the hun-
dreds of Kuwaiti oil well fires that burned between February
and November, 1991, but close proximity to oil well fires was
not ruled out as a risk factor for GWI (Research Advisory
Committee, 2008). Two recent studies have provided addi-
tional evidence supporting long-termhealth effects in veteran
subgroups that were most highly exposed to oil well fire
smoke. A study of Kansas City-area GW veterans identified a
significantly increased risk for GWI among GW veterans
exposed to oil well fire smoke among personnel in forward
areas in theater (Steele et al., 2012). Exposure to airborne
pollutants from the Kuwaiti oil well fires has also been asso-
ciated with increased risk for death due to brain cancer (Barth
et al., 2009).
Multiple investigations have identified a high degree of
overlap or clustering among GW exposures, indicating thatpersonnel with some exposures (e.g., certain pesticides) were
alsomuchmore likely to have additional exposures of concern
(e.g., other pesticides, PB Boyd et al., 2003; Cherry et al., 2001b;
Fricker et al., 2000; Steele et al., 2012). Most veterans experi-
enced exposures to chemical mixtures in theater, and a large
body of research using animal models has demonstrated
persistent effects from combinations of GW exposures not
seen with individual exposures. However, effects of these
complex exposures have been minimally evaluated in GW
veterans and remain unknown. Improved modeling of the
contributions of individual and combined exposures would
inform the assessment of mixed exposures as causes of GWI,
as would the development of biomarkers of past exposures to
specific chemicals of interest.3.5. Genetic factors
Genetic vulnerabilities to chemicals present in theater likely
played a role in the post-deployment health of individual
veterans (IOM, 2010; RACGWI, 2014). A recently published
population study of 304 GW veterans identified a significant
geneeexposure interaction in a subgroup of veterans with
GWI. This study found that veterans with less active genetic
variants of the butyrylcholinesterase enzyme were at sub-
stantially greater risk for GWI if they used PB compared to
veterans with these genotypes who did not use PB (Steele,
Lockridge, Gerkovich, Cook, & Sastre, 2015).4. Neuropathology of GWI
Because the most prominent symptoms of GWI are so clearly
related to nervous system function and because GW veterans
were exposed to several well-known neurotoxicants in the-
ater, research has focused on the nervous system in attempts
to identify the underlying neuropathological mechanisms of
the disorder. Other systems, including the immune, respira-
tory, and gastrointestinal systems, have also received atten-
tion, though to a lesser extent. We will focus here on the
known neuropathological and neurofunctional correlates of
GWI, mentioning other systems when they are found on the
pathway to nervous system effects.4.1. Neuroimaging
Early research using MRI and electroencephalography (EEG)
methods tended to compare ill and healthy GW veterans and
to use insensitive clinical visual interpretation of images,
finding few differences (Amato et al., 1997; Haley, Hom, et al.,
1997; Lee, Bale, & Gabriel, 2005; Levine et al., 2006; Newmark&
Clayton, 1995). Since 2008, 16 additional peer-reviewed EEG
and neuroimaging papers have appeared, with more sophis-
ticated methodology and closer attention to exposur-
eeoutcome relationships. Table 5 summarizes two papers
that describe exposure-related neuroimaging findings in GW
veterans. Table 6 summarizes 13 additional studies that uti-
lized imaging and EEG to characterize structural and func-
tional alterations in relation to symptomatic illness in GW
veterans.
Table 6 e EEG and brain imaging findings in symptomatic Gulf War veterans.
Study Groups studied Method(s) Key findings
MRI and SPECT
Haley et al., 2009 21 GWV with Haley syndromes,
17 veteran controls
SPECT Syndrome 2 showed significantly lower
resting nrCBF compared to controls and
other syndrome groups. Reduction most
apparent in caudate head, globus
pallidus, putamen and posterior
thalamus. Subjects with Syndrome 2
showed elevated nrCBF while other
groups showed reduced nrCBF after
physostigmine stimulation.
Weiner et al., 2011 81 symptomatic GWV, 101 intermediate
GWV, 97 deployed veteran controls
MRI, MRS No significant differences in NAA and
NAA metabolites in the basal ganglia
and pons between symptomatic and
control veterans.
Rayhan, Raksit, et al., 2013;
Rayhan, Ravindran, et al., 2013;
Rayhan, Stevens, et al., 2013
15 symptomatic GWV, 11 veteran
and civilian controls
fMRI, MRS Prefrontal lactate levels prior to exercise
predicted whether symptomatic GWV
showed increased or decreased memory
test scores.
Physostigmine challenge test
Li et al., 2011 35 GWV with Haley syndromes,
13 veteran controls
MRI-based ASL Abnormal hippocampal CBF persists in
symptomatic GWV at baseline. Patients
with Syndromes 2 and 3 showed
significantly increased bilateral rCBF in
hippocampi after physostigmine
stimulation.
Liu et al., 2011 33 GWV with Haley syndromes,
14 nonsymptomatic veteran controls
MRI-based ASL Expected physostigmine decrease in CBF
was absent in symptomatic GWV, who
showed either no change or increased
CBF after cholinergic challenge.
Physostigmine response differences
between GWV and controls most
pronounced in amygdala, hippocampus,
caudate and thalamus.
Structural MRI
Calley et al., 2010 53 GWV with Haley syndromes,
16 nonsymptomatic deployed GWV
fMRI Significant signal change increase in the
thalamic region and signal change
decrease in the caudate in Syndrome 2
subjects compared to Syndrome 1 and
controls. Syndrome 2 subjects showed
significantly positive association
between reaction time on SORT task and
percent signal change in bilateral
caudate heads. Syndrome 1 and 3
subjects performed significantly worse
on SORT compared to deployed controls.
Chao et al., 2011 64 GWV with suspected sarin or cyclosarin
exposure matched to 64 unexposed GWV
MRI Sarin and cyclosarin exposed GWV
showed significantly reduced total gray
and white matter volumes compared to
unexposed controls. GWI/CMI diagnosis
significantly predicted gray and white
matter volumes in sarin and cyclosarin
exposed subjects. No doseeresponse
relationships seen.
fMRI
Gopinath et al., 2012 40 GWV with Haley syndromes,
14 veteran controls
fMRI In response to innocuous heat, subjects
with Syndromes 1 and 2 showed
significantly reduced activation in the
insula, S1, S2, SMA, medial PPC, IPL,
premotor cortex and DMPFC in
compared to controls. Syndrome 1 and 2
exhibited significantly more activation
to innocuous heat in the ventral anterior
cingulate.
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Table 6 e (continued )
Study Groups studied Method(s) Key findings
Hubbard et al., 2013 96 symptomatic GWV,
44 matched controls
fMRI Significant differences were seen
between groups for prefrontal cortex
activity during a working memory task,
indicating that GWVs allocate high
demand working memory loads
differently from controls.
Rayhan, Raksit, et al., 2013;
Rayhan, Ravindran, et al., 2013;
Rayhan, Stevens, et al., 2013
28 symptomatic GWV,
10 civilian controls
fMRI The GWI post-exercise orthostatic
tachycardia subgroup showed
brainstem atrophy and baseline working
memory compensation in the vermis.
The other GWI subgroup exhibited
hyperalgesia in response to exercise,
and had baseline working memory
compensation in the basal ganglia when
compared to controls. GWV showed
impaired working memory compared to
controls.
Rayhan, Raksit, et al., 2013;
Rayhan, Ravindran, et al., 2013;
Rayhan, Stevens, et al., 2013
31 GWV with CFS and CMI,
12 sedentary control veterans
fMRI In GWV diagnosed with CMI or CFS,
white matter integrity loss was
identified in cortico-cortical and
corticospinal areas. Changes in axial
diffusivity in the IFOF significantly
different between controls and CFS/CMI
GWV.
EEG
Tillman et al., 2012 20 GWV with Haley syndromes,
8 deployed asymptomatic GWV
ERP from EEG Haley syndrome group predicted P1
amplitude, P1 latency, with longer
latencies in syndromes 2 and 3
compared to controls and Syndrome 1.
Mean P3a amplitudes significantly
different between syndromes 1 and 2
compared to controls and syndrome 3.
Tillman et al., 2013 22 GWV with Haley syndromes,
8 deployed asymptomatic GWV
ERP from EEG Significantly lower P3b amplitudes in 3
syndrome groups compared to controls
in an oddball attention task.
Abbreviations: GWV ¼ Gulf War veterans; PTSD ¼ post-traumatic stress disorder; SORT¼ Semantic object retrieval test; MRI ¼ magnetic
resonance imaging; fMRI ¼ functional magnetic resonance imaging; GWI ¼ Gulf War illness; CMI ¼ chronic multisymptom illness;
CSF ¼ cerebrospinal fluid; S1¼ Primary somatosensory cortex; S2¼ Secondary somatosensory cortex; SMA ¼ supplementary motor area;
PPC ¼ posterior parietal cortex; IPL ¼ inferior parietal lobule; DMPFC ¼ dorsomedial prefrontal cortex; SPECT¼ Single Photon Emission
Computed Tomography; nrCBF ¼ normalized regional cerebral blood flow; rCBF ¼ regional cerebral blood flow; ASL ¼ arterial spin labeling;
CFS ¼ chronic fatigue syndrome; IFOF ¼ inferior fronto-occipital fasciculus; MRS ¼magnetic resonance spectroscopy; MS ¼multiple sclerosis;
EEG ¼ electroencephalogram; ERP ¼ event related potential; NAA¼N-acetyl aspartate; VV¼Vietnam veterans; PHG ¼ parahippocampal gyrus;
STC ¼ superior temporal cortex; OFC ¼ orbital frontal cortex; PO ¼ pars orbitalis.
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troscopy reported lower levels of several metabolites (choline,
creatine, N-acetylaspartate [NAA]) using proton magnetic
resonance spectroscopy (H-MRS) in the brainstems and basal
ganglia in GWveteranswhomet Haley criteria for diagnosis of
GWI (Haley et al., 2000) and lowered NAA/creatine ratios in
basal ganglia (Meyerhoff, Lindgren, Hardin, Griffin, &Weiner,
2001) and hippocampus (Menon, Nasrallah, Reeves, & Ali,
2004). Research conducted by Weiner (2005) identified brain
metabolic abnormalities in choline/creatine ratios in GW
veterans meeting Haley Syndrome 2 (Confusion-ataxia)
criteria for GWI (Weiner, 2005). However, a later study (Weiner
et al., 2011) failed to confirm this finding: NAA, creatine and
choline levels did not differ significantly in symptomatic
versus asymptomatic GW veterans (Weiner et al., 2011).
Rayhan, Raksit, et al. (2013), Rayhan, Ravindran, et al. (2013)and Rayhan, Stevens, et al. (2013) assessed lactate metabo-
lite levels in the prefrontal cortex prior to and after an exercise
challenge in ill GW veterans, finding that pre-exercise lactate
level was associated withmemory performance pre-and post-
exercise. A single-photon emission computer tomography
(SPECT) method that injects a radioactive tracer to produce a
3-D representation of metabolic activity in the brain was used
to evaluate cerebral blood flow in 21 subjects diagnosed with
Haley Syndrome 2 (Confusion-ataxia) compared to 17 military
controls; significantly lower cerebral blood flow in the
caudate, globus pallidus, putamen and posterior hypothala-
mus was seen in the ill veterans (Haley et al., 2009).
Because exposures experienced by GW veterans in theater
included many chemicals that act on the cholinergic system
(sarin, cyclosarin, organophosphates e OPs, PB; Golomb,
2008), one approach to imaging in this population employed
c o r t e x 7 4 ( 2 0 1 6 ) 4 4 9e4 7 5462physostigmine infusions to challenge the cholinergic system
and evaluate the challenge effects. Table 6 summarizes three
recent investigations utilizing physostigmine challenge. Using
MRS probes, Li et al. (2011) detected abnormal cerebral blood
flow through the hippocampus before the physostigmine
challenge, and after the challenge veterans with Haley Syn-
dromes 2 (Confusion-ataxia) and 3 (Neuropathic pain) showed
significantly abnormal increases in regional cerebral blood flow
in the hippocampus of both hemispheres. A second physo-
stigmine challenge study failed to find any decrease in brain
activity in symptomatic GW veterans; instead, GWI patients
showed either no change or increased cerebral blood flow
after physostigmine injection, with changes being statistically
significantly different from sedentary control veterans. Dif-
ferences were most significant in the hippocampus, amyg-
dala, caudate and thalamic areas after physostigmine
injection (Liu et al., 2011). Similar elevated cerebral blood flow
results with physostigmine challenge were also reported in a
study using SPECT methodology (Haley et al., 2009).
Reduced white and gray matter volumes in cortical areas
have been consistently reported in structural MRI studies of ill
GW veterans (Chao et al., 2011, 2010; Rayhan, Stevens, et al.,
2013; Rosenzweig, Bodi, & Nashef, 2012). Reduced signaling
was also seen in the thalamus, caudate, hippocampus, globus
pallidus and putamen (Calley et al., 2010; Haley et al., 2009; Li
et al., 2011). As noted above and in Table 6, Chao et al. (2011)
found that GWI and CMI diagnoses significantly predicted
volume changes in sarin and cyclosarin-exposed subjects.
Several studies have used functional MRI (fMRI) to assess
functional anomalies and white matter integrity using diffu-
sion tensor imaging (DTI). For example, Rayhan, Raksit, et al.
(2013), Rayhan, Ravindran, et al. (2013) and Rayhan, Stevens,
et al. (2013) reported that fatigue, pain and hyperalgesia
were associatedwith diminishedwhitematter integrity in GW
veterans with CMI or CFS (Rayhan, Stevens, et al., 2013). Axial
diffusivity in the right inferior fronto-occipital fasciculus
specifically predicted CMI diagnosis in this study. In addition,
civilian controls and ill GW veterans exposed to exercise
revealed two distinct GWI phenotypes. One subgroup dis-
played orthostatic tachycardia while the other developed
hyperalgesia. Imaging results on both groups showed signs of
brain atrophywhen compared to controls and alteredworking
memory compensation in brain areas that were different from
controls. In a second study, fMRI scanning of 53 symptomatic
GW veterans showed significant signal changes in the
thalamic and caudate regions in Haley Syndrome 2 (Confu-
sion-ataxia) subjects when compared to other symptomatic
veterans and healthy controls. Furthermore, the Haley Syn-
drome 2 group's performance on a semantic learning task was
associated with signal change in the caudate areas bilaterally
(Calley et al., 2010).
Responses to an innocuous heat stimulus in symptomatic
and control GW veterans was investigated using fMRI meth-
odology in a study by Gopinath et al. (2012). Compared to
Haley Syndrome 3 (Neuropathic pain) patients and controls,
patients with Haley Syndromes 1 (Impaired cognition) and 2
(Confusion-ataxia) showed significantly reduced brain activity
in the insula, somatosensory areas S1 and S2, the medial
prefrontal cortex, supplementarymotor area, premotor cortex
and dorsolateral prefrontal cortex. An investigation using aworking memory challenge task during fMRI concluded that
symptomatic GW veterans showed distinctive prefrontal
cortical activity when compared to civilian controls consistent
with impairments in central executive processing (Hubbard
et al., 2013).
Using an EEG task that measures hyperarousability,
(Tillman et al., 2012) significant associations were found
between P1 latency and amplitude in veterans with Haley
Syndrome diagnoses 2 (Confusion-ataxia) and 3 (Neuropathic
pain) when compared to healthy controls and Haley Syn-
drome 1 (Impaired cognition) subjects. GW veterans with
Syndromes 1 and 2 showed P3a amplitudes that were signifi-
cantly different from controls and Syndrome 3 subjects. In a
follow-up study, significantly lower P3b amplitudes were seen
in all three syndrome groups when compared to controls
(Tillman et al., 2013).
As a group, studies that utilize imaging and EEG probes
when investigating veteranswith GWI defined in variousways
and when assessing GW veterans with sarin/cyclosarin
exposure consistently identify structural and electrical ab-
normalities in the central nervous system: 14 of the 15 papers
published since 2008 and summarized in Tables 5 and 6 sup-
port this conclusion.
4.2. Neurocognition
GWI symptoms commonly include complaints about memory
and concentration as well as dysregulated mood. These
symptoms have been systematically investigated in this
population through neuropsychological assessments in order
to provide objective, quantified and standardized measure-
ments of specific brain and behavioral functions. Early
research comparing deployed GW veterans and nondeployed
era veterans found that affective and mood complaints often
differentiated the two groups, with greater dysphoria among
the deployed veterans. However, overall comparisons be-
tween deployed and nondeployed era veterans generally
failed to reveal cognitive differences in the two groups. Sig-
nificant differences tended to emerge only in research that
compared deployed veterans with and without GWI and that
compared veterans who experienced specific exposures in
theater to deployed veterans who did not experience these
exposures.
Several investigations published prior to 2009 concluded
that visuospatial and motor skills were poorer and greater
dysphoria was evident in deployed veterans with GWI
compared to healthy GW veterans (Anger et al., 1999; Axelrod
& Milner, 1997; Binder et al., 1999; Bunegin, Mitzel, Miller,
Gelineau, & Tolstykh, 2001; Lange, Van Niekerk, & Meyer,
2001; Storzbach et al., 2000; Storzbach, Rohlman, Anger,
Binder, & Campbell, 2001; Sullivan et al., 2003). A subgroup
of GW veterans who were markedly slower on psychomotor
taskswas identified in one study, suggesting that theremay be
subgroups within the GWI population who are markedly
impaired (Anger et al., 1999; Storzbach et al., 2001). Self-
reported exposure to PB was found to be associated with
poorer performance on tests assessing executive function and
with greater mood complaints (Sullivan et al., 2003; White
et al., 2001). Self-reported exposure to chemical and biolog-
ical warfare agents predicted greater difficulty on
Table 7 e Neurocognitive findings in Gulf War veterans.
Study Groups studied Key findings
Odegard et al., 2013 10 GWV Haley Syndrome 1; 12 GWV
Haley Syndrome 2; 11 GWV Haley
Syndrome 3; 14 GWV well controls
Control GWV and GWV with Haley Syndrome 1 provided significantly more
recall responses to face-name items than GWVs with Haley Syndrome 3.
Memory performance was related to activation in the left hippocampus.
Tillman et al., 2010 25 GWV with major cognitive
complaints; 23 matched GWV controls
The experimental group had significantly more false positives and
significantly fewer hits than the control group suggesting inhibition
difficulties. The mean P3 amplitude of the patient group was significantly
lower than the control group, and also demonstrated a condition effect with
decreased amplitude during the NOGO condition.
Toomey et al., 2009 1,061 deployed GWV;
1128 nondeployed GWV
Eight factors were generated accounting for 68% of variance including
verbal memory, attention/working memory, visual memory, executive
functioning, perceptual motor speed, visual organization, motor speed, and
sustained attention. With a cutoff of 2 SD below the mean the deployed
group performed worse on motor speed and sustained attention. The
deployed group performed significantly worse on Trails B compared to the
nondeployed group. Self-reported exposure to contaminated food or water
was a significant predictor of performance in sustained attention.
Khamisiyah exposure was a significant predictor of verbal memory
performance, CARC/paint and receipt of IG were significant predictors of
visual memory performance, and SCUD missiles and vaccines of motor
speed performance.
Wallin et al., 2009 25 deployed GWV with CDC defined
GWI; 16 deployed GWV without
CDC defined GWI
No significant differences were found between GWI cases and controls in
assessed cognitive domains. GWI cases and controls mean scores were both
within normal limits compared to population based normative samples.
GWI cases mean scores were all lower than controls. GWI cases were
significantly more impaired on measures of mood and quality of life.
Abbreviations: GWV ¼ Gulf War veteran; CARC ¼ chemical agent resistant coating; IG ¼ immunoglobulin; SD ¼ standard deviation; CDC ¼
Centers for Disease Control.
(Table adapted from RACGWVI, 2014).
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well as poorer affective function among deployed veterans
(White et al., 2001). And modeled sarin and cyclosarin expo-
sure experienced by GW veterans in relation to the Khami-
siyah demolition was associated with poorer performance on
tests of psychomotor speed and visuospatial skills (Proctor
et al., 2006).
Table 7 lists four neuropsychological assessment studies
published since 2008. Toomey et al. (2009) identified differ-
ences between deployed and nondeployed veterans in a large
study (N ¼ 1061 deployed, N ¼ 1128 nondeployed), with
deployed veterans showing slower motor speed and worse
attention. Also noted in this studywas poorer performance on
neuropsychological tests within certain domains that was
associated with specific self-reported exposures. Sustained
attention was poorer in veterans with self-reported exposure
to contaminated food andwater, verbal memory performance
was worse among veterans who reported being at Khami-
siyah (and presumably exposed to sarin/cyclosarin), visual
memory was poorer in veterans with self-reported CARC
paint exposure, and motor speed was slower among veterans
who reported being near SCUD missiles (Toomey et al., 2009).
As already summarized, Chao et al. found relationships be-
tween modeled exposure to nerve gas agents from the Kha-
misiyah demolition and cognition in one study that was
related to volumetric MRI measures (Chao et al., 2010) but
cognitive findings from a second investigation were incon-
sistent (Chao et al., 2011; see Table 6). A small investigation
that assessed 25 deployed and 16 nondeployed veterans re-
ported no differences in cognitive outcomes, but measuresassessing quality of life and mood did differentiate the two
groups (Wallin et al., 2009). This study must be viewed with
caution given low power to detect differences between
groups. In another study, a GO-NOGO task was administered
while veterans with self-reported cognitive problems under-
went EEG and results were compared to control GW veterans;
the veterans with cognitive complaints were less able to
inhibit inappropriate responses than the controls (Tillman
et al., 2010). A face-name paradigm was used by Odegard
et al. (2013) to compare performance among GW veterans
with the Haley syndromes and healthy controls. Haley Syn-
drome 3 (Neuropathic pain) veterans performed worse than
those with Haley Syndrome 1 (Impaired cognition) and
healthy controls.4.3. Autonomic nervous system (ANS)
ANS dysregulation in GW veterans was noted in several early
studies reviewed in the 2008 RAC report. Findings included
significant differences between symptomatic and healthy
veterans in relation to 24-h heart rate variability (HRV; Haley
et al., 2004; Stein et al., 2004), increased HRV in symptomatic
veterans after exposure to diesel vapors (Fiedler et al., 2004),
differential blood pressure, heart rate, and symptomatic re-
sponses with tilt table testing (Clauw, 2001; Davis, Kator,
Wonnett, Pappas, & Sall, 2000; Lucas, Armenian, Debusk,
Calkins, & Rowe, 2005; Sastre & Cook, 2004) and blunted
blood pressure response to cognitive stressors (Peckerman
et al., 2003, 2000). No statistical differences were identified in
c o r t e x 7 4 ( 2 0 1 6 ) 4 4 9e4 7 5464tests of sympathetic skin response and airway pressure
response (Sharief et al., 2002).
A more recent study identified several significant ANS
differences between GW veterans meeting criteria for the
three Haley syndromes and controls. GW veterans meeting
any of the three syndrome criteria scored worse than controls
on the Autonomic Symptom Profile questionnaire, due to
higher self-reports of gastrointestinal distress, sleep and uri-
nary dysfunction and orthostatic intolerance. They also
received higher Composite Autonomic Severity scores, and
Syndrome 2 (Confusion-ataxia) veterans showed significantly
reduced sweat response. This study also found diminished
night-time HRV in all three syndrome groups (Haley et al.,
2013).4.4. Neuroendocrine function
Although clinical neuroendocrine disorders have not typi-
cally been observed in GW veterans, a series of studies
conducted by Golier and colleagues investigated hypotha-
lamic-pituitary-adrenal (HPA) axis parameters in GW vet-
erans for over a decade. This work revealed that cortisol
suppression in response to dexamethasone was signifi-
cantly related to musculoskeletal symptoms and was more
pronounced in GW veterans reporting PB use (Golier, Legge,
& Yehuda, 2006; Golier, Schmeidler, Legge, & Yehuda, 2006).
In addition, this line of research consistently revealed pat-
terns of HPA-axis functioning in GW veterans that are
distinct from those seen in other conditions, including
depression, PTSD and CFS (Golier, Caramanica, & Yehuda,
2012; Golier, Schmeidler, Legge, & Yehuda, 2007; Golier,
Schmeidler, & Yehuda, 2009). Preliminary findings relevant
to other hypothalamicepituitary parameters were recently
reported by clinical investigators in the U.K., who identified
a variety of abnormalities in blood hormone levels, most
prominently gonadotropin releasing hormone, in a small
series of symptomatic GW veterans (Wakil, Sathyapalan, &
Atkin, 2011).4.5. Mitochondrial dysfunction
SomeGW-related exposures, such as organophosphates (OPs),
can be toxic to mitochondria, producing symptoms such as
fatigue and brain, muscle, gastrointestinal (GI), sleep and
autonomic dysfunction, all symptoms that are seen in GWI
(Odegard et al., 2013). Phosphocreatine is a back-up energy
source for muscle that is depleted during exercise, and the
speed of recovery is dependent on the rate of mitochondrial
ATP synthesis. Post-exercise phosphocreatine recovery rate
(PCr-R) assessed using 31-phosphorus magnetic resonance
spectroscopy has been confirmed as a robust measure of
mitochondrial defects in vivo (Thompson, Kemp, Sanderson,&
Radda, 1995). A caseecontrol study compared PCr-R in veter-
ans with GWI and in age-, sex- and ethnicity-matched con-
trols. A significant PCr-prolongation indicating delayed
recovery was seen in the veterans with GWI, supporting the
study hypothesis that mitochondrial dysfunction is a mech-
anism of GWI (Koslik, Hamilton, & Golomb, 2014).5. Animal models of GWI etiology and
pathology
Animal studies have identified biological effects of GW expo-
sures and combinations of exposures that were previously
unknown. The evidence concerning these effects has bur-
geoned since 2008, with new animalmodels of GWI evaluating
persistent and delayed effects of exposures in theater. It is
axiomatic that animals are not humans and conclusions from
animal studies must be used as clues that can be further
investigated in appropriate human research. However, the
outcomes from animal studies are important because data on
exposureeoutcome relationships can be collected rapidly and
efficiently to provide mechanistic insights.
Animal models have been used to characterize the effects
of pesticides, PB, insect repellants, nerve agents and stress,
either administered alone or in combination. Multiple studies
published prior to 2008 established that neurobiological ef-
fects of low-dose sarin exposure resulted in delayed and
persistent effects in animals (Henderson et al., 2002; RACGWI,
2008). Early animalmodels of PB established that this drug can
adversely affect nerve function (Drake-Baumann & Seil, 1999;
Hudson, Foster, & Kahng, 1985) and can also have gastroin-
testinal (Kluwe, Page, Toft, Ridder, & Chung, 1990), muscular
(Adler, Deshpande, Foster, Maxwell, & Albuquerque, 1992),
immune (Peden-Adams et al., 2004) and cardiovascular
(Bernatova, Babal, Grubbs, & Morris, 2006) effects. Rodents
given PB over time showed a number of locomotor, learning
and behavioral deficits (Abou-Donia, Dechkovskaia, Goldstein,
Bullman, & Khan, 2002; Abou-Donia et al., 2001; van Haaren
et al., 2001), despite showing no overt signs of cholinergic
toxicity or illness. Three studies in rodent models found that
the adverse effects of PB were enhanced by stressors (Abdel-
Rahman, Abou-Donia, El-Masry, Shetty, & Abou-Donia, 2004;
Abdel-Rahman, Shetty, & Abou-Donia, 2002; Friedman et al.,
1996). Other studies showed reduced levels of acetylcholin-
esterase (AChE) in the brains of animals given PB and exposed
to stressors (Baireddy, Mirajkar, Nallapaneni, Singleton, &
Pope, 2007; Sinton, Fitch, Petty, & Haley, 2000). PB adminis-
tered with the nerve agent sarin produced locomotor deficits
(Abou-Donia et al., 2002; Scremin et al., 2003), EEG abnormal-
ities (van Helden et al., 2004), changes in HRV (Scremin et al.,
2003) and increasedmarkers of oxidative stress in urine (Shih,
Hulet, & McDonough, 2006).
Since 2008, a large number of animal studies have built on
earlier findings, further elaborating relationships between GW
theater exposures and the symptoms of GWI. This work is
summarized in Table 8. It has focused on behavior, cognition,
neurotransmission and intracellular signaling; molecular and
cellular disruptions of axonal transport, and genomic and
proteomic profiling to identify previously unknown targets of
GW exposures.5.1. Altered behavior, cognitive function,
neurotransmission and intracellular signaling
OPs have been shown to inhibit the enzyme AChE and can
covalently bind organophosphorylate serine residues
throughout the body. Mice exposed to low doses of PB, a
Table 8 e Studies using animal and in Vitro models of Gulf War illness and related diseases.
Study Model Parameter(s)
evaluated exposure
Key findings
Abdullah et al., 2011 Mouse PB, PER Exposed mice demonstrated significantly increased
anxiety behavior, memory impairment and psychomotor
dysfunction. After 150 days of exposure, significant
increases in astrogliosis were seen in exposed mice.
Proteomic analysis showed significant expression
alterations for proteins that regulate lipid metabolism,
molecular transport, and endocrine and immune function.
Abdullah et al., 2012 Mouse PB, PER, DEET, stress Significant increases in ether-containing PC, diacyl, PC and
SM lipids, indicating altered transport, uptake, storage and
synthesis in ACh pathways in the brain. Anxiety-like
behavior was increased in exposed mice, especially in
females. Sensorimotor deficits were also significantly
associated with exposure, as was astrogliosis.
Abdullah et al., 2013 Mouse PB, PER Exposed mice had elevated brain levels of PC and SM
phospholipid species, particularly those containing ether
PC. Brain catalase staining was higher in exposed than
control mice. Lyso-platelet activating factors (precursors of
inflammatory lipid mediators) were decreased in the brain
and blood from exposed compared to control mice.
Bozkurt et al., 2010 Rat CPF Single CPF dose led to significant short term (12 h) changes
in glial and neuronal markers in serum. Immediate
significant changes in body weight and temperature
persisted for approximately 168 h.
Cardona et al., 2006 Rat CPF CPF significantly inhibited AChE and APF enzymatic
activity even when signs of acute toxicity were absent.
Striatum and brainstem areas showed slowed AChE
recovery after CPF exposure.
Corbel et al., 2009 Insect and mouse
cultured tissue
DEET DEET application to insect CNS neuronal preparation
produced significant initial increase in neuronal
electrophysiological activation, followed by a significant
decrease, indicating changes in synaptic transmission and
inhibition of cholinesterase activity.
Grigoryan et al., 2008 Bovine protein isolate Sarin, soman, CPO, DFP,
FP-biotin
Pesticide agents bind covalently to tubulin, a protein
required for neuronal transport, putatively creating axonal
transport deficits.
Grigoryan et al., 2009 Bovine, human, porcine
and murine protein isolate
FP-biotin OP esters bind to tyrosine in proteins across different
species. OP-reactive proteins include enzymes with and
without active serine sites.
Grigoryan et al., 2009 Bovine, human, porcine,
murine protein isolate
DFP, CPO OP esters covalently bind to lysine in albumin, keratin,
actin, tubulin and transferrin in a number of mammalian
species.
Jiang et al., 2010 Mouse CPF, CPO Microtubules isolated from brain tissue from exposedmice
showed fewer associated proteins than control mice, and
microtubules from exposed mice were significantly
smaller in comparison to controls. Mice brains show CPO-
labeled tubulin after injections of nontoxic doses of CPF or
CPO.
Middlemore-Risher
et al., 2011
Rat CPF, CPO Mitochondrial length, number and axonal movement were
decreased in central nervous system neurons in rats
exposed to CPF or CPO when compared to controls.
Nutter et al., 2013 Rat CPF, PER, PB After exposure, Kþ channel kinetics were altered in
vascular pain receptors, with significant increases in
electrophysiological excitability. No behavioral differences
were noted between exposed and control animals, nor
were significant effects seen in Naþ channel activity.
O'Callaghan
et al., 2015
Mouse DFP, DEET, CORT Pretreatment with CORT greatly increased
neuroinflammatory responses to DFP. Minocycline (anti-
inflammatory) suppressed DFP þ CORT
neuroinflammation.
Ojo et al., 2013 Mouse CPF, PB, PER Exposure to CPF alone or in combination with PB and PER
reduced synaptic function by reducing hippocampal
(continued on next page)
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Study Model Parameter(s)
evaluated exposure
Key findings
synaptophysin and impairing cell differentiation in the
dentate gyrus, with altered basal ACh levels throughout
the brain.
Parihar et al., 2013 Rat DEET, PER, PB, stress Exposure to low doses of DEET, PER and PB increased
disordered mood and cognitive behaviors. Rats exposed to
pesticides and stress showed significantly reduced
hippocampal volume and neuron growth, and increased
CNS inflammation.
Speed et al., 2012 Mouse CPF Mice injected with CPF showed a short term increase in
synaptic transmission in the CA3eCA1 hippocampal
region. After three months, decreased spine density in the
hippocampus and reduced synaptic activity was seen in
exposed versus control mice.
Torres-Altoro
et al., 2011
Mouse CPF, sarin, PB, DEET, DFP CPF and PB altered dopaminergic and glutamatergic
synaptic transmission in vivo and slice preparations.
Combined PB/DEET/DFP exposure stimulated aberrant
brain specific protein expression in the striatum and
hippocampus.
Abbreviations: PB¼ pyridostigmine bromide; PER ¼ permethrin; DEET ¼ N,N-diethyl-meta-toluamide; PC ¼ phosphatidylcholine;
SM¼ sphingomyelin; ACh¼ acetylcholine; DU¼ depleted uranium; CPF¼ chlorpyrifos; CNS¼ central nervous system; CPO¼ chlorpyrifos oxon;
DFP ¼ diisopropylfluorophosphate; FP-biotin ¼ 10-fluoroethoxyphosphinyl-N-biotinamidopentyldecanamide; OP ¼ organophosphorus;
AChE ¼ acetylcholinesterase; APF ¼ acylpeptide hydrolase; LV ¼ left ventricular; TH ¼ tyrosine hydroxylase; PC ¼ phosphatidylcholine;
SM ¼ sphingomyelin; DU ¼ depleted uranium; ROS ¼ reactive oxygen species; CORT ¼ corticosterone.
(Table adapted from RACGWVI, 2014).
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permethrin (PER; a pyrethroid-based pesticide) showed
elevated levels of the reservoir compounds necessary for
acetylcholine synthesis (Abdullah et al., 2013). Ten days of
chlorpyrifos (CPF) exposure in combination with PB and PER
increased basal acetylcholine levels in the brains of six-month
oldmice.Within the dentate gyrus, exposedmice had reduced
immunostaining for a marker of immature neuronal cells and
a synaptic vesicle protein (Ojo et al., 2013). In addition, there
was an increase in astrogliosis within the prefrontal cortex
and a reduction in several vascular injury markers within the
whole brain homogenates in exposed mice compared to
controls. Animal models also showed impairments in spatial
navigation andmemory after GWI-related exposures (Parihar,
Hattiangady, Shuai, & Shetty, 2013). Combined stress and
pesticide exposure chronically over four weeks produced
significant increases in glial-related inflammation, reduced
neuronal growth in the hippocampus and reduced overall
hippocampal volume at testing two months post-exposure
(Parihar et al., 2013).
Hippocampal synaptic transmission and reduced neuronal
spine density were observed at three months post CPF expo-
sure by Speed et al. (2012). These data support the hypothesis
that acute exposures to CPF at low dosages can produce long
lasting changes to brain areas involved in cognition without
producing obvious signs of cholinergic toxicity. Exposure to
CPF, PER and PB produced changes in Kþ channel kinetics and
excitability in muscle pain receptors, even though no behav-
ioral changes were seen (Nutter, Jiang, & Cooper, 2013).
Exposure of mice to PB and DEET for two weeks followed by
exposure to the sarin surrogate, diisopropylfluorophosphate
(DFP), or exposure to one week of CPF, resulted in deficits in
signaling through glutamatergic receptors in the striatum(Torres-Altoro et al., 2011). Exposure of mice to DFP also re-
sults in neuroinflammation in multiple brain areas, effects
which are markedly exacerbated by prior exposure to corti-
costerone as a stressor surrogate (O'Callaghan, Kelly, Locker,
Miller, & Lasley, 2015). Taken together, evidence from animal
studies suggests that subtle brain changes at the neuronal
signaling and structural levels could underlie some of the
symptoms experienced by GW veterans. Month-long expo-
sures to permethrin, PB and DEET with and without a brief
exposure to restraint stress produced mood and cognitive
changes in animal models and was consistent with neuro-
inflammatory changes in hippocampal brain areas (Parihar
et al., 2013).
OPs have been shown to disruptmultiple functions beyond
those linked strictly to AChE. While AChE inhibition from
exposures that occurred in the GW (e.g., sarin and CPF) have
been implicated in the etiology of GWI (Golomb, 2008), other
studies have identified additional secondary pathways of OP
effects apparently unrelated to inhibition of AChE (see review;
Terry, 2012). A notable non-cholinergic target of OPs is the
process of axonal transport, a key nervous system function for
transporting molecules (e.g., RNA and proteins) and subcel-
lular organelles (e.g., mitochondria and synaptic vesicles)
through the cytoplasm of axons (Terry, 2012). OPs can affect
axonal transport directly through altering microtubule struc-
ture by binding to tubulin required for transport function
(Grigoryan et al., 2008). This and similar covalent interaction
of OPs with proteins to alter their function is not limited to
binding to serine residues, because tyrosine is also bound by
OP esters (Grigoryan et al., 2009), suggesting effects on energy
metabolic/mitochondrial function at dosages too low to
inhibit AChE. The direct consequences of OP binding (e.g., CPF)
on transport has been visualized in vitro and shown to affect
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below those that inhibit AChE (Middlemore-Risher, Adam,
Lambert, & Terry, 2011). Effects of OPs on axonal transport
were accompanied by changes in behavior associated with
impairments in attention, memory and other aspects of
cognition after exposure of rats to the OP CPF and the sarin
surrogate DFP (Terry, 2012). Thus, axonal transport disruption
by OPs relevant to exposures in the 1991 GW can result in
deficits in cognition in animal models that resemble symp-
toms in ill veterans. As with most animal models of GWI
studied to date, future evaluations of GW exposures on axonal
transport would benefit from combined exposures at low
levels. Nevertheless, studies that have been conducted since
2008 clearly indicate that low levels of OPs can adversely affect
a key CNS process that may serve as a partial mechanistic
explanation for symptoms associated with GWI.
Chronic exposures to PB and PER and to PB, PER, DEET and
restraint stress to recapitulate exposures that occurred in the
GW were applied in a in a mouse model by Abdullah and
colleagues (Abdullah et al., 2011, 2012, 2013). Results revealed
novel effect domains. Phospholipids key to lipid metabolism,
axonal transport and endocrine and immune function were
implicated. These effects were accompanied by behavioral
findings indicating sensory, motor and memory impairments
as well as subtle effects on glial morphology suggestive of
underlying neuropathology and/or neuroimmune alterations.
Together these data show the value of obtaining a broader
perspective of the effect domains associated with exposure to
GW-related agents. These studies serve as a template to
discover additional pathways and systems disrupted by GW-
related exposures.
In summary, animal models of GW-relevant exposures to
individual chemicals, chemical mixtures, and chemicals plus
other stressors have demonstrated alterations in nervous
system outcomes (behavior, cognition, neurotransmission,
intracellular signaling, molecular and cellular disruptions of
axonal transport); liver and cardiovascular function; genomic,
proteomic, lipidomic and metabolomic profiles, and mito-
chondrial changes. These studies have confirmed hypotheses
that exposures are important in the development and
expression of GWI symptomatology, that health effects due to
exposures and exposure mixtures are often delayed and that
persistent effects can be seen long after exposure has ended.6. Conclusions/discussion
6.1. Prevalence and case definitions of GWI and other
disorders affecting GW veterans
The disorder known as GWI has been investigated systemat-
ically since the early 1990's. Prevalence has been most validly
characterized as the excess of diagnostic indicators of the
disorder in deployed GW veterans relative to veterans who
served during the same period but did not deploy to the GW.
The two most commonly used case definitions are CMI
(Fukuda et al., 1998) and the Kansas definition (Steele, 2000).
Using these two definitions, prevalence of GWI is estimated to
be about 25e32% in deployed GW veterans (RACGWI, 2008,
2014). Application of the more narrowly defined Haleycriteria (Haley, Kurt, et al., 1997) tends to result in much lower
prevalence estimates for GWI. Although these definitions
have frequently been characterized as “symptom-based” and
not related to known medical diagnoses, GWI symptoms are
consistent with those seen in chemically induced toxic in-
juries and residual encephalopathies (Baker et al, 1985) and
are associated with a range of objectively-measured biological
alterations. Prognosis for recovery is understudied but ap-
pears to be poor.
Neurological disorders also occur in GW veterans. They
may occur in connection with GWI (e.g., migraine headaches,
neuritis or neuralgia) or as separate disorders, possibly
occurring on a continuumwith GWI. ALS, stroke, brain cancer
and seizures have been identified at excess rates in deployed
GW veterans, and brain cancer has been related to specific
chemical exposures in theater. Given the presence of white
matter anomalies in some subgroups of GW veterans, there
has been concern that MS might also occur at higher rates in
this population. However, the data required to draw valid
conclusions about MS have not been systematically collected
or analyzed. Because PD is also sometimes seen in patient
groups with chemical exposures, this disorder also remains a
condition of concern; the status of knowledge about GW
deployment-related PD is similar to that of MS.
Studies evaluating psychiatric disorders among deployed
GW veterans have consistently shown that combat and other
psychological stressors are associated with PTSD, anxiety,
depression and alcohol abuse. However, psychological
stressors are not significant predictors of GWI diagnosis and
PTSD occurs at much lower rates in the deployed GW popu-
lation than GWI. While some patients with GWI report
dysphoria and sleep problems, these may reflect neuropath-
ological effects of GW exposures (organic affective symptoms)
and/or the consequences of being chronically ill with a
debilitating condition for many years.
6.2. Etiology of GWI and neurological dysfunction
Across all studies and populations and since the earliest
findings appeared linking self-reported exposures to diagnosis
of GWI, two types of theater-related exposures have been
consistently identified as risk factors for the disorder: expo-
sures to pesticides and PB use. In research controlling for
concurrent exposures, pesticide exposures were significantly
associated with GWI in six of seven GW populations evalu-
ated, and PB exposure was significantly associated in all seven
of the populations studied. In addition, research that assessed
the relationship between degree of exposure to pesticides and
PB has consistently identified significant positive doseeeffect
relationships between degree of exposure and likelihood of
GWI diagnosis (greater exposure is associated with higher
likelihood of GWI diagnosis). Further evidence on the long-
term residual effects of pesticides and PB carried out many
years after the war using neurocognitive and neuroendocrine
assays suggests significant sequelae of these exposures:
neurocognitive research has shown that higher exposures to
PB and pesticides are associated with decrements in cognitive
function and they are also associated with alterations in HPA
parameters in investigations of neuroendocrine function.
Multiple studies using animal models of PB and pesticide
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sures) have identified persistent and delayed structural
changes in the brain and CNS as well as neurobehavioral
dysfunction that are consistent with the symptomatology
associated with GWI. And the profiles of symptoms and dec-
rements in neurocognitive function identified in GW veterans
parallel those seen in dozens of studies of occupational groups
exposed to pesticides and pesticide mixtures. Taken together,
these multiple lines of evidence suggest that exposure to
pesticides and PB use are causally associated with GWI and
other neurological consequences in GW veterans.
Research evaluating the relationship between exposure to
the nerve agents sarin and cyclosarin and ill health in
deployed veterans has consistently shown that modeled
exposure to these agents is associated with structural brain
differences on MRI (especially total white and grey matter
volumes), with neurocognitive outcomes and with mortality
due to brain cancer. The limited evidence on the relationships
between these exposures and diagnosis of GWI has been
inconsistent and inconclusive. More research on these expo-
sures is needed to determine if they are causative for GWI.
Exposure to oil well fire smoke has also been less well
studied and may be linked to GWI, respiratory disorders and
brain cancer mortality, but more research is needed to make
conclusions. The research to date on vaccines is also limited,
with inadequate evidence to persuasively support a link be-
tween GWI and specific types of vaccines or the number of
vaccines received.
6.3. Pathobiology of GWI and neurological and
neuroimmune function in GW veterans
Because GWI is a multi-system illness, human studies on
pathobiology have been difficult to pursue, particularly with
regard to basic underlying mechanisms that may induce
multiple symptoms and types of dysfunction. There is clear
neurological pathology in this population. Studies of veterans
with GWI defined in various ways and in veterans exposed to
nerve gas agents that utilize varying imaging and EEG probes
consistently identify structural and electrical abnormalities in
the central nervous system: 14 of the 15 papers published
since 2008 support this conclusion, as does a sizable literature
published earlier. Similarly, neurocognitive research on GW
veterans has consistently revealed exposure-related
dysfunction among deployed GW veterans and differences
between ill and healthy GW veterans suggestive of structural
and functional CNS pathology.
Some GWI symptoms imply ANS involvement and early
research consistently suggested that ANS dysfunction was
prominent in GWI. This has been less well studied recently,
but remains a likely contributing factor in the pathobiology of
the disorder.
Neuroendocrine and immune dysregulation have also
been reported in a number of studies, including those using
protocols that demonstrate pronounced differences after ex-
ercise and other challenges. Specific patterns of altered HPA-
axis functioning that are quite distinct from other condi-
tions, including PTSD, have been reported in a long line of
research. And one recent study has provided evidence of sig-
nificant mitochondrial dysfunction in veterans with GWI.Further studies are warranted to determine the exact nature
of identified alterations, whichmay lead to treatment options.
6.4. Animal models of GWI and theater exposures
Research on animal models of GW exposures and of GWI has
contributed a great deal to our understanding of the expo-
sureeoutcome relationships and underlying mechanisms of
GWI and other health issues in deployed GW veterans. These
studies have examined the acute, chronic, and lasting residual
effects of single and mixed exposures to PB, OPs, permethrin,
DEET, nerve gas agents and experimental stressors on CNS
outcomes. Results have shown both delayed and persistent
effects (including effects seen an extended time after expo-
sure has ended) on behavior, cognition, neurotransmission,
intracellular signaling, andmolecular and cellular transport in
the CNS as well as liver and cardiovascular function, mito-
chondrial function, and genomic, proteomic, lipidomic and
metabolomic profiles. Genomic and proteomic surveys have
implicated phospholipids essential to lipid metabolism,
axonal transport and endocrine and immune function. These
effects were seen in the context of sensory, motor and
memory impairments and changes in glial morphology.
Taken together, the animal research supports the plausibility
of the occurrence of multi-system health complaints existing
long after exposure as well as underlying neuropathological
and neuroimmune mechanisms of GWI and other disorders
and dysfunctions in exposed GW veterans.
6.5. The bottom line
The research data to date on health in GW veterans converge
to support these conclusions:
- Between one-fourth and one-third of deployed GW
veterans are affected by a disorder characterized by
chronic symptoms involving multiple body systems;
this condition is best identified by the term GWI.
- This disorder was caused by toxicant exposures, indi-
vidually or in combination, that occurred in the GW
theater. At present, research most clearly and consis-
tently links pesticide and PB exposures to GWI, while
exposures to low-level nerve gas agents, contaminants
from oil well fires, multiple vaccinations, and combi-
nations of these exposures cannot be ruled out.
- In addition to GWI, deployed GW veterans suffer from a
variety of neurological disorders, alone or in combina-
tion with GWI. ALS, brain cancer, stroke, migraine
headaches, neuritis and neuralgia have all been re-
ported as occurring at higher rates in this population.
Rates of disorders such as MS and PD are unknown and
further intensive research is needed to determine
whether they are elevated in GW veterans. This should
include studies focused on GW veteran subgroups
classified by individual exposures or geographic loca-
tions in theater.
- Neurological disorders as well as alterations in brain
structure and function have been linked to specific ex-
posures in theater, including nerve gas agents, PB and
oil well fires
c o r t e x 7 4 ( 2 0 1 6 ) 4 4 9e4 7 5 469- The state of knowledge on the health of deployed GW
veterans supports the conclusion that they are suffering
from persistent pathology due to chemical intoxication
(sometimes referred to by veterans as “toxic wounds”).
- Further research into the mechanisms and etiology of
the health problems of GW veterans is critical to
developing biomarkers of exposure and illness and
preventing similar problems for military personnel in
future deployments; this information is also critical for
developing new treatments for GWI and related
neurological dysfunction.
- Given the similarity of the health problems of GW vet-
erans and those of other occupational groups with OP
exposures (e.g., insecticide applicators, farmers, sheep
dippers, nursery workers, chemical plant workers), the
identification of treatments for the GW veteran popu-
lation will have far-reaching implications for treating
other groups of ill patients for whom no effective
treatments have been identified.
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